Inspired heat shock protein alleviating prodrug enforces immunogenic photodynamic therapy by eliciting pyroptosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inspired heat shock protein alleviating prodrug enforces immunogenic photodynamic therapy by eliciting pyroptosis
Authors
Keywords
-
Journal
Nano Research
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-16
DOI
10.1007/s12274-021-3946-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
- (2021) Sheera R. Rosenbaum et al. Cancer Discovery
- The Next Decade of Immune Checkpoint Therapy
- (2021) Padmanee Sharma et al. Cancer Discovery
- Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
- (2021) Xianbin Ma et al. Acta Pharmaceutica Sinica B
- Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
- (2020) Daixi Ren et al. Molecular Cancer
- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- Gasdermin E suppresses tumour growth by activating anti-tumour immunity
- (2020) Zhibin Zhang et al. NATURE
- A bioorthogonal system reveals antitumour immune function of pyroptosis
- (2020) Qinyang Wang et al. NATURE
- Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
- (2020) Zhiwei Zhou et al. SCIENCE
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
- (2020) Yun Liu et al. JOURNAL OF CONTROLLED RELEASE
- Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
- (2020) Rong Tang et al. Journal of Hematology & Oncology
- Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy
- (2020) Dan Wu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy
- (2020) Pengfei Zhao et al. BIOMATERIALS
- Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer
- (2020) Xuan Yi et al. Science Advances
- Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
- (2020) Elisabeth Pérez-Ruiz et al. DRUG RESISTANCE UPDATES
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- Bioresponsive prodrug nanogel-based polycondensate strategy deepens tumor penetration and potentiates oxidative stress
- (2020) Xianbin Ma et al. CHEMICAL ENGINEERING JOURNAL
- Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Combining Nanomedicine and Immunotherapy
- (2019) Yang Shi et al. ACCOUNTS OF CHEMICAL RESEARCH
- Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation
- (2019) Corey Rogers et al. Nature Communications
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- Eradication of unresectable liver metastasis through induction of tumour specific energy depletion
- (2019) Da Huo et al. Nature Communications
- Quantitative Drug Release Monitoring in Tumors of Living Subjects by Magnetic Particle Imaging Nanocomposite
- (2019) Xingjun Zhu et al. NANO LETTERS
- Smart cancer nanomedicine
- (2019) Roy van der Meel et al. Nature Nanotechnology
- Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
- (2019) Zhiyong Wang et al. Nature Communications
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Formation of plasmon quenching dips greatly enhances 1O2 generation in a chlorin e6–gold nanorod coupled system
- (2018) Hui Zhang et al. Nano Research
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
- (2018) Tae Kon Kim et al. TRENDS IN IMMUNOLOGY
- Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
- (2018) Xiang Ling et al. ACS Nano
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis
- (2018) Bo Zhou et al. CELL RESEARCH
- Rational Design of IR820- and Ce6-Based Versatile Micelle for Single NIR Laser-Induced Imaging and Dual-Modal Phototherapy
- (2018) Xu Hu et al. Small
- Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway
- (2017) Akira Wagatsuma et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
- (2017) Yupeng Wang et al. NATURE
- HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
- (2017) Rina M. Mbofung et al. Nature Communications
- Caspases Connect Cell-Death Signaling to Organismal Homeostasis
- (2016) Lorenzo Galluzzi et al. IMMUNITY
- Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
- (2015) Nobuhiko Kayagaki et al. NATURE
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
- (2013) Kan He et al. MOLECULAR CANCER THERAPEUTICS
- A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis
- (2011) F. Lamoureux et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started